Pra Health Sciences Inc Revenue Growth Rates (PRAH), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Pra Health Sciences Inc   (NASDAQ: PRAH)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

PRAH's Revenue Growth by Quarter and Year

Pra Health Sciences Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRAH Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 933.78
FY 933.78

PRAHs Annual Revenue
Pra Health Sciences Inc 's Revenue in the fiscal year 2020 $ 3,183.37 millions
Pra Health Sciences Inc 's Revenue in the fiscal year 2019 $ 3,066.26 millions
Pra Health Sciences Inc 's Revenue in the fiscal year 2018 $ 2,871.92 millions
Pra Health Sciences Inc 's Revenue in the fiscal year 2017 $ 2,259.39 millions
Pra Health Sciences Inc 's Revenue in the fiscal year 2016 $ 1,811.71 millions




PRAH Revenue first quarter 2021 Y/Y Growth Comment
Pra Health Sciences Inc achieved in the first quarter 2021, above Company average Revenue increase of 19.15% year on year, to $ 933.78 millions.

Looking into first quarter 2021 results within Medical Laboratories industry 14 other companies have achieved higher Revenue growth. While Pra Health Sciences Inc ' s Revenue growth of 19.15% ranks overall at the positon no. 1459 in the first quarter 2021.


PRAH Revenue ( Y/Y Growth %) 2021
 2020 2019 2018
4th Quarter December - 9.15 % 9.67 % 11.24 %
3rd Quarter September - 2 % 8.79 % 23.3 %
2nd Quarter June - -4.38 % 5.6 % 35.43 %
1st Quarter March 19.15 % 8.54 % 2.88 % 43.89 %
FY   - 3.82 % 6.77 % -

Financial Statements
Pra Health Sciences Inc 's first quarter 2021 Revenue $ 933.78 millions PRAH's Income Statement
Pra Health Sciences Inc 's first quarter 2020 Revenue $ 783.71 millions Quarterly PRAH's Income Statement


PRAH Revenue (Quarter on Quarter Growth %)

 2021
 2020 2019 2018
4th Quarter December - 9.69 % 2.5 % 1.68 %
3rd Quarter September - 9.1 % 2.28 % -0.72 %
2nd Quarter June - -6.87 % 5.72 % 2.99 %
1st Quarter March 6.91 % -2.07 % -1.05 % 7 %
FY (Year on Year)   - 3.82 % 6.77 % -


Back to PRAH Growth rate Comparisons >> Back to PRAH Growth rate Comparisons >>


Revenue first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #15
Healthcare Sector #247
Overall #1459

Revenue Y/Y Growth Statistics
High Average Low
43.89 % 15.34 % -4.38 %
(Mar 31 2018)   (Jun 30 2020)
Revenue first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #15
Healthcare Sector #247
Overall #1459
Revenue Y/Y Growth Statistics
High Average Low
43.89 % 15.34 % -4.38 %
(Mar 31 2018)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Pra Health Sciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
12.7 % 3.82 % -6.87 %
(Dec 31 2017)  


PRAH's I. Quarter Q/Q Revenue Comment
Pra Health Sciences Inc achieved in the I. Quarter 2021 above company average sequential Revenue increase of 6.91%, to $ 933.78 millions, from $873.46 millions in the fourth quarter.

Within Medical Laboratories industry 8 other companies have achieved higher Revenue quarter on quarter growth. While Pra Health Sciences Inc 's Revenue growth quarter on quarter, overall rank is 1203.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #9
Healthcare Sector #166
Overall #1203
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #9
Healthcare Sector #166
Overall #1203
Revenue Q/Q Growth Statistics
High Average Low
12.7 % 3.82 % -6.87 %
(Dec 31 2017)  


PRAH's I. Quarter Q/Q Revenue Comment
Pra Health Sciences Inc achieved in the I. Quarter 2021 above company average sequential Revenue increase of 6.91%, to $ 933.78 millions, from $873.46 millions in the fourth quarter.

Within Medical Laboratories industry 8 other companies have achieved higher Revenue quarter on quarter growth. While Pra Health Sciences Inc 's Revenue growth quarter on quarter, overall rank is 1203.


Pra Health Sciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2021)		 12 Months Ending
(Dec 31 2020)		 12 Months Ending
(Sep 30 2020)		 12 Months Ending
(Jun 30 2020)		 12 Months Ending
(Mar 31 2020)
Cumulative Revenue 12 Months Ending $ 3,333.43 $ 3,183.37 $ 3,110.15 $ 3,094.53 $ 3,127.95
Y / Y Revenue Growth (TTM) 6.57 % 3.82 % 3.82 % 5.52 % 8.15 %
Year on Year Revenue Growth Overall Ranking # 1491 # 641 # 522 # 0 # 1172
Seqeuential Revenue Change (TTM) 4.71 % 2.35 % 0.5 % -1.07 % 2.01 %
Seq. Revenue Growth (TTM) Overall Ranking # 1841 # 680 # 987 # 0 # 1448


Cumulative Revenue growth Comment
Although Pra Health Sciences Inc 's Annual Revenue growth year on year were below company's average 15.79% , Revenue announced in the Mar 31 2021 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 6.57% year on year, from 3.82% in Dec 31 2020.

In the Healthcare sector 257 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 641 to 1491.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 21
Healthcare Sector # 258
Overall # 1491

Revenue TTM Y/Y Growth Statistics
High Average Low
36.74 %
 15.79 %
3.82 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 282
S&P 500 # 1841
Cumulative Revenue growth Comment
Although Pra Health Sciences Inc 's Annual Revenue growth year on year were below company's average 15.79% , Revenue announced in the Mar 31 2021 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 6.57% year on year, from 3.82% in Dec 31 2020.

In the Healthcare sector 257 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 641 to 1491.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 21
Healthcare Sector # 258
Overall # 1491

Revenue TTM Y/Y Growth Statistics
High Average Low
36.74 %
15.79 %
3.82 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 282
S&P 500 # 1841




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PRAH's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2021
Healthlynked Corp33.49%$ 33.491 millions
Adamas Pharmaceuticals Inc33.35%$ 33.354 millions
Merus N v 32.52%$ 32.519 millions
Talphera Inc 32.38%$ 32.383 millions
Novocure Limited32.28%$ 32.277 millions
Delcath Systems Inc 31.97%$ 31.973 millions
Orthopediatrics Corp31.22%$ 31.218 millions
Icad Inc31.21%$ 31.212 millions
Castle Biosciences Inc 30.97%$ 30.974 millions
Waters Corporation30.89%$ 30.887 millions
Bruker Corporation30.83%$ 30.825 millions
Axonics Inc 30.72%$ 30.716 millions
Rapt Therapeutics Inc 30.70%$ 30.695 millions
Harrow Inc 30.68%$ 30.685 millions
Elutia Inc 30.63%$ 30.630 millions
Vericel Corporation29.57%$ 29.575 millions
Oncternal Therapeutics Inc 29.41%$ 29.412 millions
Clearpoint Neuro Inc 29.35%$ 29.349 millions
Apollo Endosurgery inc 29.29%$ 29.287 millions
Sarepta Therapeutics Inc 29.26%$ 29.256 millions
Ppd Inc 28.52%$ 28.525 millions
Assertio Holdings inc 28.31%$ 28.312 millions
Karyopharm Therapeutics Inc 28.24%$ 28.239 millions
Axogen inc 27.93%$ 27.930 millions
Alpha Pro Tech Ltd 27.58%$ 27.581 millions
Insulet Corporation27.42%$ 27.424 millions
Antares Pharma Inc 27.22%$ 27.220 millions
Chembio Diagnostics Inc 27.18%$ 27.185 millions
Bio rad Laboratories Inc 27.14%$ 27.141 millions
Albireo Pharma inc 26.92%$ 26.921 millions


About Pra Health Sciences Inc Revenue Growth Rates (PRAH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.